Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.
Adverse drug reactions (ADRs) are common and mostly avoidable. Some ADRs cannot as yet be predicted, but at-risk populations/patients and high-risk drugs are identifiable. HIV-infected patients are at risk of developing cutaneous ADRs, especially Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug hypersensitivity syndrome. Multiple factors of causation variably present in patients with HIV infection best explain the pathogenesis of these cutaneous ADRs. When no effective alternate therapy is available, drug rechallenge in HIV-infected patients can be attempted with little morbidity or mortality if done according to rationalized protocols.
Todd
Gail
G
Division of Dermatology, University of Cape Town, Faculty of Health Sciences, Nard 623, Cape Town, South Africa. gtodd@UCTGSH1.uct.ac.za
D003875:Drug Eruptions / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D004342:Drug Hypersensitivity / Q000150:complications / Q000175:diagnosis / Q000473:pathology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D013262:Stevens-Johnson Syndrome / Q000150:complications / Q000175:diagnosis / Q000473:pathology